In the world of business pivots, few are as inspiring as that of Kat Cole, the current CEO of AG1, formerly known as Athletic Greens.
Once a waitress at Hooters, Cole climbed the corporate ladder to become a vice president, and later, she sweetened her resume at Cinnabon’s parent company, Focus Brands.
Today, she stands at the helm of a health supplement company valued at a staggering $1.2 billion in 2022, a testament to her adaptability and vision.
AG1 has become a household name, especially among athletes and wellness influencers.
With endorsements from high-profile figures like Formula One driver Lewis Hamilton and Olympic runner Allyson Felix, AG1’s green multivitamin and nutrient powder have capitalized on a burgeoning market.
Yet, despite its success, the supplement industry faces skepticism, particularly from some medical professionals who question the necessity of multivitamins.
Cole’s career transition from fast food to health supplements isn’t just a professional pivot; it’s a personal journey.
A mother who faced health challenges in her family, Cole emphasizes the importance of nutrition and wellness.
In a conversation with Most Innovative Companies host Yasmin Gagne, she shared how her personal experiences have shaped her professional endeavors.
“Health became a bigger part of where I believe consumers were going,” she noted, highlighting a shift in consumer consciousness towards longevity and nutrition.
Under Cole’s leadership, AG1 has grown exponentially, boasting projected revenues of $600 million, a marked increase from $160 million at the end of 2021.
This growth has been driven by a commitment to quality and transparency, with AG1 investing in human clinical trials and third-party certifications to distinguish itself in a crowded market.
In an era where consumers are bombarded with choices, such credibility is invaluable.
Interestingly, AG1’s customer base defies expectations, with an even gender split.
Initially, Cole herself assumed the product would primarily attract male biohackers.
However, she discovered a burgeoning interest among women, particularly those over 45, who are seeking to supplement their health as they age.
The pandemic has accelerated this trend, with more women pursuing strength and wellness rather than traditional ideals of delicacy.
As AG1 contemplates its next moves, one potential path involves bringing its products to retail shelves.
Cole’s experience at Focus Brands, where she successfully placed products like Cinnabon in various sections of grocery stores, could provide a blueprint for AG1’s retail strategy.
The prospect of in-store sampling and education could open new consumer segments, bridging the gap between AG1’s strong online presence and brick-and-mortar retail.
Despite its impressive growth trajectory, the question of whether AG1 will go public remains unanswered.
The company has managed to maintain investor confidence by tripling its business since its last valuation, an achievement that speaks volumes in an industry often fraught with volatility.
AG1’s future innovations will likely focus on foundational nutrition, enhancing its core product rather than diversifying too quickly.
This strategy aligns with Cole’s philosophy of addressing customers’ needs at various life stages and maintaining clarity in a complex market.
Kat Cole’s journey with AG1 is a testament to the power of reinvention, both personal and professional.
As the health landscape continues to evolve, her leadership could very well guide AG1 to redefine what it means to supplement one’s health in the modern world.
